Medications & Supplements/Over-the-Counter

AuroMedics Pharma LLC: Ranitidine 150 mg Tablets Recalled for Empty Bottles

Agency Publication Date: October 29, 2019

Summary

AuroMedics Pharma LLC is recalling one lot (approximately 69,696 bottles) of Ranitidine Tablets USP, 150 mg. The recall was issued because some 8-count bottles were found to be empty, which could lead to consumers missing their medication doses. These products were distributed nationwide by Dolgencorp, LLC and have an expiration date of February 2021.

Risk

If a consumer receives an empty bottle, they will miss their intended dose of ranitidine, which is used to treat or prevent stomach ulcers and acid reflux. This could result in a lack of treatment for the patient's gastric condition, though no injuries or adverse events have been reported.

What You Should Do

Check your medicine cabinet for 8-count bottles of Ranitidine Tablets USP, 150 mg with NDC 55910-092-79 on the label.
Verify the lot number and expiration date: this recall only affects lot number NBSB19001DA3 with an expiration date of 02/2021.
If you have an affected bottle, do not attempt to use it or rely on it for your medication schedule.
Contact your healthcare provider or pharmacist immediately for guidance on your treatment and to obtain a replacement.
Return any unused or empty bottles from this specific lot to the pharmacy or place of purchase for a full refund.
For further instructions, contact the manufacturer, AuroMedics Pharma LLC, or the FDA Consumer Complaint line at 1-888-723-3332.

Your Remedy Options

Full Refund

Refund for affected product lot.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Ranitidine Tablets USP, 150 mg (8-count bottles)

Model:

NDC 55910-092-79

Lot Numbers:

NBSB19001DA3 (Exp. date 02/2021)

Date Ranges: Expiration 02/2021

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 83868

Status: Active

Manufacturer: AuroMedics Pharma LLC

Sold By: Dolgencorp, LLC; Dollar General

Manufactured In: India, United States

Units Affected: 69696 bottles

Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your medicine cabinet for 8-count bottles of Ranitidine Tablets USP, 150 mg with NDC 55910-092-79 on the label.

Verify the lot number and expiration date: this recall only affects lot number NBSB19001DA3 with an expiration date of 02/2021.

If you have an affected bottle, do not attempt to use it or rely on it for your medication schedule.

Contact your healthcare provider or pharmacist immediately for guidance on your treatment and to obtain a replacement.

Return any unused or empty bottles from this specific lot to the pharmacy or place of purchase for a full refund.

For further instructions, contact the manufacturer, AuroMedics Pharma LLC, or the FDA Consumer Complaint line at 1-888-723-3332.